Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.
Standard
Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. / Rosenkranz, Daniela; Weyer, Sascha; Tolosa, Eva; Gaenslen, Alexandra; Berg, Daniela; Leyhe, Thomas; Gasser, Thomas; Stoltze, Lars.
in: J NEUROIMMUNOL, Jahrgang 188, Nr. 1-2, 1-2, 2007, S. 117-127.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.
AU - Rosenkranz, Daniela
AU - Weyer, Sascha
AU - Tolosa, Eva
AU - Gaenslen, Alexandra
AU - Berg, Daniela
AU - Leyhe, Thomas
AU - Gasser, Thomas
AU - Stoltze, Lars
PY - 2007
Y1 - 2007
N2 - The involvement of regulatory T cells (Treg) in autoimmune-disease development has been demonstrated. However, their alteration during ageing and age-related diseases has not been thoroughly investigated yet. Alzheimer (AD) and Parkinson disease (PD), are related to protein-misfolding and are accompanied by neuroinflammation. Since, it has been hypothesized that the neuroinflammation attempts to prevent disease development, we speculated that changes in Treg might affect any relevant immune mechanism. The analysis of Treg from AD and PD patients as well as non-affected individuals, revealed that the frequency of Treg (CD4(+)Foxp3(+)) increases with age and is accompanied by intensified suppressive activity for Treg in patients.
AB - The involvement of regulatory T cells (Treg) in autoimmune-disease development has been demonstrated. However, their alteration during ageing and age-related diseases has not been thoroughly investigated yet. Alzheimer (AD) and Parkinson disease (PD), are related to protein-misfolding and are accompanied by neuroinflammation. Since, it has been hypothesized that the neuroinflammation attempts to prevent disease development, we speculated that changes in Treg might affect any relevant immune mechanism. The analysis of Treg from AD and PD patients as well as non-affected individuals, revealed that the frequency of Treg (CD4(+)Foxp3(+)) increases with age and is accompanied by intensified suppressive activity for Treg in patients.
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Age Factors
KW - Case-Control Studies
KW - Forkhead Transcription Factors/metabolism
KW - Aging/immunology
KW - Alzheimer Disease/immunology/pathology
KW - CD4-Positive T-Lymphocytes/physiology
KW - Flow Cytometry/methods
KW - Parkinson Disease/immunology/pathology
KW - T-Lymphocyte Subsets
KW - T-Lymphocytes, Regulatory/physiology
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Age Factors
KW - Case-Control Studies
KW - Forkhead Transcription Factors/metabolism
KW - Aging/immunology
KW - Alzheimer Disease/immunology/pathology
KW - CD4-Positive T-Lymphocytes/physiology
KW - Flow Cytometry/methods
KW - Parkinson Disease/immunology/pathology
KW - T-Lymphocyte Subsets
KW - T-Lymphocytes, Regulatory/physiology
M3 - SCORING: Journal article
VL - 188
SP - 117
EP - 127
JO - J NEUROIMMUNOL
JF - J NEUROIMMUNOL
SN - 0165-5728
IS - 1-2
M1 - 1-2
ER -